Cargando…

Prevalence and epidemiology of meningococcal carriage in Southern Ethiopia prior to implementation of MenAfriVac, a conjugate vaccine

BACKGROUND: Neisseria meningitidis colonizes humans and transmits mainly by asymptomatic carriage. We sought to determine the prevalence and epidemiology of meningococcal carriage in Ethiopia prior to the introduction of MenAfriVac, a serogroup A meningococcal conjugate vaccine. METHODS: A cross-sec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bårnes, Guro K., Kristiansen, Paul A., Beyene, Demissew, Workalemahu, Bereket, Fissiha, Paulos, Merdekios, Behailu, Bohlin, Jon, Préziosi, Marie-Pierre, Aseffa, Abraham, Caugant, Dominique A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5097444/ https://www.ncbi.nlm.nih.gov/pubmed/27814682 http://dx.doi.org/10.1186/s12879-016-1975-3

Ejemplares similares

Persistent low carriage of serogroup A Neisseria meningitidistwo years after mass vaccination with the meningococcal conjugate vaccine, MenAfriVac
por: Kristiansen, Paul A, et al.
Publicado: (2014)

MenAfriVac as an Antitetanus Vaccine
por: Borrow, Ray, et al.
Publicado: (2015)

Evolution of meningococcal carriage in serogroups X and Y before introduction of MenAfriVac in the health district of Kaya, Burkina Faso
por: Ba, Absatou Ky, et al.
Publicado: (2014)

Whole genome sequencing reveals within-host genetic changes in paired meningococcal carriage isolates from Ethiopia
por: Bårnes, Guro K., et al.
Publicado: (2017)

Influence of Age on Antibody Response and Persistence Following Immunization With MenAfriVac
por: Tang, Yuxiao, et al.
Publicado: (2015)

Introduction of Preventive Vaccination of Meningococcal Meningitis using MenAfriVac in Northern Uganda 2017
por: Ssewankambo, Fred
Publicado: (2017)

Modeling Long-term Vaccination Strategies With MenAfriVac in the African Meningitis Belt
por: Karachaliou, Andromachi, et al.
Publicado: (2015)

Immunogenicity of Yellow Fever Vaccine Coadministered With MenAfriVac in Healthy Infants in Ghana and Mali
por: Roy Chowdhury, Panchali, et al.
Publicado: (2015)

Community Perspectives Associated With the African PsA-TT (MenAfriVac) Vaccine Trials
por: Idoko, Olubukola T., et al.
Publicado: (2015)

Efficacy and Effectiveness of the Meningococcal Conjugate Group A Vaccine MenAfriVac(®) in Preventing Recurrent Meningitis Epidemics in Sub-Saharan Africa
por: Viviani, Simonetta
Publicado: (2022)

Understanding the Role of Duration of Vaccine Protection with MenAfriVac: Simulating Alternative Vaccination Strategies
por: Karachaliou Prasinou, Andromachi, et al.
Publicado: (2021)

A Phase 3, Double-Blind, Randomized, Active Controlled Study to Evaluate the Safety of MenAfriVac in Healthy Malians
por: Tapia, Milagritos D., et al.
Publicado: (2015)

Impact of MenAfriVac on Meningococcal A Meningitis in Cameroon: A Retrospective Study Using Case-by-Case-Based Surveillance Data from 2009 to 2015
por: Gake, Bouba, et al.
Publicado: (2021)

Antibody Persistence 1–5 Years Following Vaccination With MenAfriVac in African Children Vaccinated at 12–23 Months of Age
por: Tapia, Milagritos D., et al.
Publicado: (2015)

Knowledge, beliefs and practices regarding prevention of bacterial meningitis in Burkina Faso, 5 years after MenAfriVac mass campaigns
por: Mueller, Judith E., et al.
Publicado: (2021)

Antibody Persistence at 1 and 4 Years Following a Single Dose of MenAfriVac or Quadrivalent Polysaccharide Vaccine in Healthy Subjects Aged 2–29 Years
por: Diallo, Aldiouma, et al.
Publicado: (2015)

A field based evaluation of adverse events following MenAfriVac(®)vaccine delivered in a controlled temperature chain (CTC) approach in Benin
por: Steffen, Christoph, et al.
Publicado: (2014)

Bacterial meningitis epidemiology and return of Neisseria meningitidis serogroup A cases in Burkina Faso in the five years following MenAfriVac mass vaccination campaign
por: Diallo, Alpha Oumar, et al.
Publicado: (2017)

Meningococcal carriage and disease—Population biology and evolution
por: Caugant, Dominique A., et al.
Publicado: (2009)

L’utilisation de l’approche CTC: quel impact sur la couverture vaccinale lors de la campagne préventive de vaccination contre la méningite A avec le MenAfriVac au Togo en 2014?
por: Landoh, Dadja Essoya, et al.
Publicado: (2017)

Meningococcal Carriage among Household Contacts of Patients with Invasive Meningococcal Disease in Kathmandu, Nepal: A Longitudinal Study
por: Sharma, Supriya, et al.
Publicado: (2021)

Meningococcal carriage in Norwegian teenagers: strain characterisation and assessment of risk factors
por: Watle, S. V., et al.
Publicado: (2020)

Risk factors for acquisition of meningococcal carriage in the African meningitis belt
por: Cooper, Laura V., et al.
Publicado: (2019)

Meningococcal carriage in the African meningitis belt
Publicado: (2013)

Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine
por: Kristiansen, Paul A, et al.
Publicado: (2013)

Meningococcal carriage by age in the African meningitis belt: a systematic review and meta-analysis
por: Cooper, L. V., et al.
Publicado: (2019)

Molecular studies of meningococcal and pneumococcal meningitis patients in Ethiopia
por: Mihret, Wude, et al.
Publicado: (2019)

Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa
por: Brynildsrud, Ola Brønstad, et al.
Publicado: (2018)

Social Behavior and Meningococcal Carriage in British Teenagers
por: MacLennan, Jenny, et al.
Publicado: (2006)

A comparison of meningococcal carriage by pregnancy status
por: Knudtson, Eric J, et al.
Publicado: (2010)

Narrative review of methods and findings of recent studies on the carriage of meningococci and other Neisseria species in the African Meningitis Belt
por: Greenwood, Brian M., et al.
Publicado: (2018)

Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys
por: Mbaeyi, Sarah, et al.
Publicado: (2020)

Gauging the epidemic potential of a widely circulating non-invasive meningococcal strain in Africa
por: Brynildsrud, Ola Brønstad, et al.
Publicado: (2019)

Molecular insights into meningococcal carriage isolates from Burkina Faso 7 years after introduction of a serogroup A meningococcal conjugate vaccine
por: Topaz, Nadav, et al.
Publicado: (2020)

Epidemic Meningococcal Meningitis, Cameroon
por: Massenet, D., et al.
Publicado: (2011)

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
por: Daugla, DM, et al.
Publicado: (2013)

Multidisciplinary approach to genomics research in Africa: the AfriCRAN model
por: Butali, Azeez, et al.
Publicado: (2015)

Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil
por: Nunes, Amélia Maria Pithon Borges, et al.
Publicado: (2016)

The Influence of IS1301 in the Capsule Biosynthesis Locus on Meningococcal Carriage and Disease
por: Kugelberg, Elisabeth, et al.
Publicado: (2010)

Molecular Characteristics and Epidemiology of Meningococcal Carriage, Burkina Faso, 2003
por: Mueller, Judith E., et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_aftjvnomtnh87esrm4i3e8vcnh